INS and metabolic disease: Myosteatosis is linked to insulin resistance and metabolic diseases including type 2 diabetes through several mechanisms including inflammatory cytokines, decreased insulin sensitivity index and glucose disposal rate and increased cholesterol [5, 35, 36, 37].